REUTERS: Bellicum Pharmaceuticals Inc said the U.S. Food and Drug Administration had placed a clinical hold on U.S. trials of the company's experimental cancer drug after three cases of brain disease linked to head trauma. Shares of the Houston-based drug developer fell 48 percent to US$5.26 in ...
- Typhoon order outlook as good as it’s been for some time: BAE CEO
- China, EU reaffirm Paris climate commitment, vow more cooperation
- Fierce heatwave hits Japan flood recovery
- Chinese ‘highway to nowhere’ haunts Montenegro
- EU urges big powers to avert trade ‘conflict and chaos’
- Thai cave boys and coach dug holes daily in hope of escape
- Trump blames Washington for poor Russia ties ahead of Putin summit